Accessing Teva’s in-house documents helped build EU sanction, official says
By Nicholas Hirst and Lewis Crofts ( September 5, 2025, 09:12 GMT | Insight) -- Teva’s in-house lawyers were involved in the company’s anticompetitive strategy to keep challengers off the market for a multiple sclerosis treatment, according to an EU antitrust investigator, who said it was important that enforcers can review internal legal communications. He said the EU watchdog continues to “actively” investigate US animal health company Zoetis.Teva’s in-house lawyers were involved in the company’s anticompetitive strategy to keep generic challengers off the market for a multiple sclerosis treatment, according to an EU antitrust investigator, who said it was important that enforcers can review internal legal communications. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.